PPARs在皮肤生理学中的意义
The Significance of PPARs in Skin Physiology
DOI: 10.12677/acm.2024.143857, PDF,   
作者: 金超颖, 吴慧玲*:浙江大学医学院,浙江 杭州;浙江大学医学院附属第一医院整形美容中心,浙江 杭州
关键词: 过氧化物酶体增殖激活受体皮肤生理学成纤维细胞角质细胞黑色素细胞毛囊皮脂腺Peroxisome Proliferator-Activated Receptors Skin Biology Fibroblast Keratinocyte Melanocyte Hair Follicle Sebaceous Gland
摘要: 过氧化物酶体增殖激活受体(PPARs)是配体激活的转录因子,属于核激素受体家族。PPARs具有3种亚型:PPARα、PPARβ/δ和PPARγ,具有不同组织分布和细胞功能。3种PPARs亚型均在皮肤中有分布,参与皮肤细胞的脂质代谢与能量代谢,与角质形成细胞的增殖和分化密切相关,调节成纤维细胞的分泌功能,介导皮脂腺的生成与免疫稳态的维持,促进黑色素细胞的分化和黑素小体的成熟,并对促进毛囊的分化发育有益。基于PPARs在皮肤中的生物学效应,PPAR激动剂或拮抗剂可能为治疗各种皮肤疾病提供新的机会。
Abstract: Peroxisome proliferator-activated receptors (PPARs) are ligand-activated transcription factors belonging to the nuclear hormone receptor family. The 3 isoforms of PPARs, which are PPARα, PPARβ/δ, and PPARγ, have different tissue distributions and cellular functions. PPARs are also found in the skin and are involved in the lipid metabolism and energy metabolism of skin cells and are closely related to proliferation and differentiation of keratinocytes and the regulation of the secretion of fibroblasts, mediate the production of sebaceous glands and the maintenance of immune homeostasis. They also promote the differentiation of melanocytes and the maturation of melanosomes. Besides, they are beneficial for the promotion of hair follicles. Based on the biological effects of PPARs in the skin, PPAR agonists or antagonists may provide new opportunities for the treatment of various skin diseases.
文章引用:金超颖, 吴慧玲. PPARs在皮肤生理学中的意义[J]. 临床医学进展, 2024, 14(3): 1396-1404. https://doi.org/10.12677/acm.2024.143857

参考文献

[1] Wahli, W., Braissant, O. and Desvergne, B. (1995) Peroxisome Proliferator Activated Receptors: Transcriptional Regulators of Adipogenesis, Lipid Metabolism and More. Chemistry & Biology, 2, 261-266. [Google Scholar] [CrossRef] [PubMed]
[2] Kuenzli, S. and Saurat, J.H. (2003) Peroxisome Proliferator-Activated Receptors in Cutaneous Biology. British Journal of Dermatology, 149, 229-236. [Google Scholar] [CrossRef] [PubMed]
[3] Venteclef, N., Jakobsson, T., Steffensen, K.R. and Treuter, E. (2011) Metabolic Nuclear Receptor Signaling and the Inflammatory Acute Phase Response. Trends in Endocrinology & Metabolism, 22, 333-343. [Google Scholar] [CrossRef] [PubMed]
[4] Issemann, I. and Green, S. (1990) Activation of a Member of the Steroid Hormone Receptor Superfamily by Peroxisome Proliferators. Nature, 347, 645-650. [Google Scholar] [CrossRef] [PubMed]
[5] Bougarne, N., Basiel, W., Sofie, J.D., et al. (2018) Molecular Actions of PPARα in Lipid Metabolism and Inflammation. Endocrine Reviews, 39, 760-802. [Google Scholar] [CrossRef] [PubMed]
[6] Kersten, S., Seydoux, J., Peters, J.M., et al. (2014) Integrated Physiology and Systems Biology of PPARα. Molecular Metabolism, 3, 354-371. [Google Scholar] [CrossRef] [PubMed]
[7] Kersten, S., (1990) Peroxisome Proliferator-Activated Receptor α Mediates the Adaptive Response to Fasting. Journal of Clinical Investigation, 103, 1489-1498. [Google Scholar] [CrossRef
[8] Settembre, C., Cegli, D.R., Mansueto, G., et al. (2013) TFEB Controls Cellular Lipid Metabolism through a Starvation-Induced Autoregulatory Loop. Nature Cell Biology, 15, 647-658. [Google Scholar] [CrossRef] [PubMed]
[9] Sanderson, L.M., Boekschoten, M.V., Desvergne, B., et al. (2010) Transcriptional Profiling Reveals Divergent Roles of PPARα and PPARβ/Delta in Regulation of Gene Expression in Mouse Liver. Physiological Genomics, 41, 42-52. [Google Scholar] [CrossRef] [PubMed]
[10] Sugden, M.C., Bulmer, K., Gibbons, G.F., et al. (2002) Peroxisome-Proliferator-Activated Receptor-α (PPARα) Deficiency Leads to Dysregulation of Hepatic Lipid and Carbohydrate Metabolism by Fatty Acids and Insulin. Biochemical Journal, 364, 361-368. [Google Scholar] [CrossRef] [PubMed]
[11] Patsouris, D., Mandard, S., Voshol, P.J., et al. (2004) PPARα Governs Glycerol Metabolism. Journal of Clinical Investigation, 114, 94-103. [Google Scholar] [CrossRef
[12] Rakhshandehroo, M., Sanderson, L.M., Matilainen, M., et al. (2007) Comprehensive Analysis of PPARα-Dependent Regulation of Hepatic Lipid Metabolism by Expression Profiling. PPAR Research, 2007, Article ID: 26839. [Google Scholar] [CrossRef] [PubMed]
[13] Xu, J., Chang, V., Joseph, S.B., et al. (2004) Peroxisomal Proliferator-Activated Receptor α Deficiency Diminishes Insulin-Responsiveness of Gluconeogenic/Glycolytic/Pentose Gene Expression and Substrate Cycle Flux. Endocrinology, 145, 1087-1095. [Google Scholar] [CrossRef] [PubMed]
[14] Makowski, L., Noland, R.C., Koves, T.R., et al. (2009) Metabolic Profiling of PPARα-/- Mice Reveals Defects in Carnitine and Amino Acid Homeostasis That Are Partially Reversed by Oral Carnitine Supplementation. FASEB Journal, 23, 586-604. [Google Scholar] [CrossRef] [PubMed]
[15] Kersten, S., Mandard, S., Escher, P., et al. (2001) The Peroxisome Proliferator-Activated Receptor α Regulates Amino Acid Metabolism. FASEB Journal, 15, 1971-1978. [Google Scholar] [CrossRef] [PubMed]
[16] Chinetti, G., Zawadski, C., Fruchart, J.C. and Staels, B. (2004) Expression of Adiponectin Receptors in Human Macrophages and Regulation by Agonists of the Nuclear Receptors PPARα, PPARγ, and LXR. Biochemical and Biophysical Research Communications, 314, 151-158. [Google Scholar] [CrossRef] [PubMed]
[17] Jones, D.C., Ding, X. and Daynes, R.A. (2002) Nuclear Receptor Peroxisome Proliferator-Activated Receptor α (PPARα) Is Expressed in Resting Murine Lymphocytes. The PPARα in T and B Lymphocytes Is Both Transactivation and Transrepression Competent. Journal of Biological Chemistry, 277, 6838-6845. [Google Scholar] [CrossRef
[18] Dunn, S.E., Ousman, S.S., Sobel, R.A., et al. (2007) Peroxisome Proliferator-Activated Receptor (PPAR)α Expression in T Cells Mediates Gender Differences in Development of T Cell-Mediated Autoimmunity. Journal of Experimental Medicine, 204, 321-330. [Google Scholar] [CrossRef] [PubMed]
[19] Serrano-Marco, L., Rodriguez-Calvo, R., El Kochairi, I., et al. (2011) Activation of Peroxisome Proliferator-Activated Receptor-β/-Delta (PPAR-β/-Delta) Ameliorates Insulin Signaling and Reduces SOCS3 Levels by Inhibiting STAT3 in Interleukin-6-Stimulated Adipocytes. Diabetes, 60, 1990-1999. [Google Scholar] [CrossRef] [PubMed]
[20] Burkart, E.M., Sambandam, N., Han, X., et al. (2007) Nuclear Receptors PPARβ/Delta and PPARα Direct Distinct Metabolic Regulatory Programs in the Mouse Heart. Journal of Clinical Investigation, 117, 3930-3939. [Google Scholar] [CrossRef
[21] Lopaschuk, G.D. and Jaswal, J.S. (2010) Energy Metabolic Phenotype of the Cardiomyocyte during Development, Differentiation, and Postnatal Maturation. Journal of Cardiovascular Pharmacology, 56, 130-140. [Google Scholar] [CrossRef
[22] Han, J.K., Lee, H.S., Yang, H.M., et al. (2008) Peroxisome Proliferator-Activated Receptor-Delta Agonist Enhances Vasculogenesis by Regulating Endothelial Progenitor Cells through Genomic and Nongenomic Activations of the Phosphatidylinositol 3-Kinase/Akt Pathway. Circulation, 118, 1021-1033. [Google Scholar] [CrossRef
[23] Scholtysek, C., Katzenbeisser, J., Fu, H., et al. (2013) PPARβ/Delta Governs Wnt Signaling and Bone Turnover. Nature Medicine, 19, 608-613. [Google Scholar] [CrossRef] [PubMed]
[24] Wagner, N., Jehl-Pietri, C., Lopez, P., et al. (2009) Peroxisome Proliferator-Activated Receptor β Stimulation Induces Rapid Cardiac Growth and Angiogenesis via Direct Activation of Calcineurin. Cardiovascular Research, 83, 61-71. [Google Scholar] [CrossRef] [PubMed]
[25] Maccallini, C., Mollica, A. and Amoroso, R. (2017) The Positive Regulation of ENOS Signaling by PPAR Agonists in Cardiovascular Diseases. American Journal of Cardiovascular Drugs, 17, 273-281. [Google Scholar] [CrossRef] [PubMed]
[26] Tang, W., Zeve, D., Suh, J.M., et al. (2008) White Fat Progenitor Cells Reside in the Adipose Vasculature. Science, 322, 583-586. [Google Scholar] [CrossRef] [PubMed]
[27] Tomaru, T., Steger, D.J., Lefterova, M.I., et al. (2009) Adipocyte-Specific Expression of Murine Resistin Is Mediated by Synergism between Peroxisome Proliferator-Activated Receptor γ and CCAAT/Enhancer-Binding Proteins. Journal of Biological Chemistry, 284, 6116-6125. [Google Scholar] [CrossRef
[28] Moore, K.J., Rosen, E.D., Fitzgerald, M.L., et al. (2001) The Role of PPAR-γ in Macrophage Differentiation and Cholesterol Uptake. Nature Medicine, 7, 41-47. [Google Scholar] [CrossRef] [PubMed]
[29] Bouhlel, M.A., Derudas, B., Rigamonti, E., et al. (2007) PPARγ Activation Primes Human Monocytes into Alternative M2 Macrophages with Anti-Inflammatory Properties. Cell Metabolism, 6, 137-143. [Google Scholar] [CrossRef] [PubMed]
[30] Cipolletta, D., Feuerer, M., Li, A., et al. (2012) PPAR-γ Is a Major Driver of the Accumulation and Phenotype of Adipose Tissue Treg Cells. Nature, 486, 549-553. [Google Scholar] [CrossRef] [PubMed]
[31] Szatmari, I., Rajnavolgyi, E. and Nagy, L. (2006) PPARγ, a Lipid-Activated Transcription Factor as a Regulator of Dendritic Cell Function. Annals of the New York Academy of Sciences, 1088, 207-218. [Google Scholar] [CrossRef] [PubMed]
[32] Sarraf, P., Mueller, E., Jones, D., et al. (1998) Differentiation and Reversal of Malignant Changes in Colon Cancer through PPARγ. Nature Medicine, 4, 1046-1052. [Google Scholar] [CrossRef] [PubMed]
[33] Bren-Mattison, Y., Van Putten, V., Chan, D., et al. (2005) Peroxisome Proliferator-Activated Receptor-γ (PPARγ) Inhibits Tumorigenesis by Reversing the Undifferentiated Phenotype of Metastatic Non-Small-Cell Lung Cancer Cells (NSCLC). Oncogene, 24, 1412-1422. [Google Scholar] [CrossRef] [PubMed]
[34] Bonofiglio, D., Cione, E., Qi, H., et al. (2009) Combined Low Doses of PPARγ and RXR Ligands Trigger an Intrinsic Apoptotic Pathway in Human Breast Cancer Cells. The American Journal of Pathology, 175, 1270-1280. [Google Scholar] [CrossRef] [PubMed]
[35] Westergaard, M., Henningsen, J., Svendsen, M.L., et al. (2001) Modulation of Keratinocyte Gene Expression and Differentiation by PPAR-Selective Ligands and Tetradecylthioacetic Acid. Journal of Investigative Dermatology, 116, 702-712. [Google Scholar] [CrossRef] [PubMed]
[36] Rivier, M., Safonova, I., Lebrun, P., et al. (1998) Differential Expression of Peroxisome Proliferator-Activated Receptor Subtypes during the Differentiation of Human Keratinocytes. Journal of Investigative Dermatology, 111, 1116-1121. [Google Scholar] [CrossRef] [PubMed]
[37] Mao-Qiang, M., Fowler, A.J., Schmuth, M., et al. (2004) Peroxisome-Proliferator-Activated Receptor (PPAR)-γ Activation Stimulates Keratinocyte Differentiation. Journal of Investigative Dermatology, 123, 305-312. [Google Scholar] [CrossRef
[38] Schmuth, M., Haqq, C.M., Cairns, W.J., et al. (2004) Peroxisome Proliferator-Activated Receptor (PPAR)-β/Delta Stimulates Differentiation and Lipid Accumulation in Keratinocytes. Journal of Investigative Dermatology, 122, 971-983. [Google Scholar] [CrossRef
[39] Xiao, Y., Wang, H., Wang, C., et al. (2020) MiR-203 Promotes HaCaT Cell Overproliferation through Targeting LXR-α and PPAR-γ. Cell Cycle, 19, 1928-1940. [Google Scholar] [CrossRef] [PubMed]
[40] Rivier, M., Castiel, I., Safonova, I., et al. (2000) Peroxisome Proliferator-Activated Receptor-α Enhances Lipid Metabolism in a Skin Equivalent Model. Journal of Investigative Dermatology, 114, 681-687. [Google Scholar] [CrossRef] [PubMed]
[41] Batheja, P., Song, Y., Wertz, P. and Michniak-Kohn, B. (2009) Effects of Growth Conditions On the Barrier Properties of a Human Skin Equivalent. Pharmaceutical Research, 26, 1689-1700. [Google Scholar] [CrossRef] [PubMed]
[42] Jiang, Y.J., Uchida, Y., Lu, B., et al. (2009) Ceramide Stimulates ABCA12 Expression via Peroxisome Proliferator-Activated Receptor Delta in Human Keratinocytes. Journal of Biological Chemistry, 284, 18942-18952. [Google Scholar] [CrossRef
[43] Jiang, Y.J., Lu, B., Kim, P., et al. (2008) PPAR and LXR Activators Regulate ABCA12 Expression in Human Keratinocytes. Journal of Investigative Dermatology, 128, 104-109. [Google Scholar] [CrossRef] [PubMed]
[44] Capolupo, L., Khven, I., Lederer, A.R., et al. (2022) Sphingolipids Control Dermal Fibroblast Heterogeneity. Science, 376, eabh1623. [Google Scholar] [CrossRef] [PubMed]
[45] Zhao, X., Psarianos, P., Ghoraie, L.S., et al. (2019) Metabolic Regulation of Dermal Fibroblasts Contributes to Skin Extracellular Matrix Homeostasis and Fibrosis. Nature Metabolism, 1, 147-157. [Google Scholar] [CrossRef] [PubMed]
[46] Majewski, G.P., Singh, S. and Bojanowski, K. (2021) Olive Leaf-Derived PPAR Agonist Complex Induces Collagen IV Synthesis in Human Skin Models. International Journal of Cosmetic Science, 43, 662-676. [Google Scholar] [CrossRef] [PubMed]
[47] Kim, S.H., Nam, G.W., Lee, H.K., et al. (2006) The Effects of Musk T on Peroxisome Proliferator-Activated Receptor [PPAR]-α Activation, Epidermal Skin Homeostasis and Dermal Hyaluronic Acid Synthesis. Archives of Dermatological Research, 298, 273-282. [Google Scholar] [CrossRef] [PubMed]
[48] Sng, M.K., Chan, J.S.K., Teo, Z., et al. (2018) Selective Deletion of PPARβ/Delta in Fibroblasts Causes Dermal Fibrosis by Attenuated LRG1 Expression. Cell Discovery, 4, Article No. 15. [Google Scholar] [CrossRef] [PubMed]
[49] Jung, Y.R., Lee, E.K., Kim, D.H., et al. (2015) Upregulation of Collagen Expression via PPARβ/Delta Activation in Aged Skin by Magnesium Lithospermate B from Salvia Miltiorrhiza. Journal of Natural Products, 78, 2110-2115. [Google Scholar] [CrossRef] [PubMed]
[50] Dozsa, A., Mihaly, J., Dezso, B., et al. (2016) Decreased Peroxisome Proliferator-Activated Receptor γ Level and Signalling in Sebaceous Glands of Patients with Acne Vulgaris. Clinical and Experimental Dermatology, 41, 547-551. [Google Scholar] [CrossRef] [PubMed]
[51] Dozsa, A., Dezso, B., Toth, B.I., et al. (2014) PPARγ-Mediated and Arachidonic Acid-Dependent Signaling Is Involved in Differentiation and Lipid Production of Human Sebocytes. Journal of Investigative Dermatology, 134, 910-920. [Google Scholar] [CrossRef] [PubMed]
[52] Trivedi, N.R., Cong, Z., Nelson, A.M., et al. (2006) Peroxisome Proliferator-Activated Receptors Increase Human Sebum Production. Journal of Investigative Dermatology, 126, 2002-2009. [Google Scholar] [CrossRef] [PubMed]
[53] Konger, R.L., Derr-Yellin, E., Zimmers, T.A., et al. (2021) Epidermal PPARγ Is a Key Homeostatic Regulator of Cutaneous Inflammation and Barrier Function in Mouse Skin. International Journal of Molecular Sciences, 22, Article 8634. [Google Scholar] [CrossRef] [PubMed]
[54] Kovacs, D., Lovaszi, M., Poliska, S., et al. (2016) Sebocytes Differentially Express and Secrete Adipokines. Experimental Dermatology, 25, 194-199. [Google Scholar] [CrossRef] [PubMed]
[55] Zouboulis, C.C. (2020) Endocrinology and Immunology of Acne: Two Sides of the Same Coin. Experimental Dermatology, 29, 840-859. [Google Scholar] [CrossRef] [PubMed]
[56] Bharti, S. and Vadlamudi, H.C. (2021) A Strategic Review on the Involvement of Receptors, Transcription Factors and Hormones in Acne Pathogenesis. Journal of Receptors and Signal Transduction, 41, 105-116. [Google Scholar] [CrossRef] [PubMed]
[57] Lin, J.Y. and Fisher, D.E. (2007) Melanocyte Biology and Skin Pigmentation. Nature, 445, 843-850. [Google Scholar] [CrossRef] [PubMed]
[58] Kang, H.Y., Chung, E., Lee, M., et al. (2004) Expression and Function of Peroxisome Proliferator-Activated Receptors in Human Melanocytes. British Journal of Dermatology, 150, 462-468. [Google Scholar] [CrossRef] [PubMed]
[59] Zhao, S., Chen, X., Dutta, K., et al. (2023) Multiple Gene-Drug Prediction Tool Reveals Rosiglitazone Based Treatment Pathway for Non-Segmental Vitiligo. Inflammation. [Google Scholar] [CrossRef] [PubMed]
[60] Lee, J.S., Choi, Y.M. and Kang, H.Y. (2007) PPAR-γ Agonist, Ciglitazone, Increases Pigmentation and Migration of Human Melanocytes. Experimental Dermatology, 16, 118-123. [Google Scholar] [CrossRef] [PubMed]
[61] Maresca, V., Flori, E., Camera, E., et al. (2013) Linking αMSH with PPARγ in B16-F10 Melanoma. Pigment Cell & Melanoma Research, 26, 113-127. [Google Scholar] [CrossRef
[62] Shoag, J., Haq, R., Zhang, M., et al. (2013) PGC-1 Coactivators Regulate MITF and the Tanning Response. Molecular Cell, 49, 145-157. [Google Scholar] [CrossRef] [PubMed]
[63] Herraiz, C., Martinez-Vicente, I. and Maresca, V. (2021) The α-Melanocyte-Stimulating Hormone/Melanocortin-1 Receptor Interaction: A Driver of Pleiotropic Effects Beyond Pigmentation. Pigment Cell & Melanoma Research, 34, 748-761. [Google Scholar] [CrossRef] [PubMed]
[64] Ramot, Y., Alam, M., Olah, A., et al. (2018) Peroxisome Proliferator-Activated Receptor-γ-Mediated Signaling Regulates Mitochondrial Energy Metabolism in Human Hair Follicle Epithelium. Journal of Investigative Dermatology, 138, 1656-1659. [Google Scholar] [CrossRef] [PubMed]
[65] Ramot, Y., Mastrofrancesco, A., Herczeg-Lisztes, E., et al. (2014) Advanced Inhibition of Undesired Human Hair Growth by PPAγ Modulation? Journal of Investigative Dermatology, 134, 1128-1131. [Google Scholar] [CrossRef] [PubMed]
[66] Imanishi, H., Ansell, D.M., Cheret, J.,et al. (2018) Epithelial-To-Mesenchymal Stem Cell Transition in a Human Organ: Lessons from Lichen Planopilaris. Journal of Investigative Dermatology, 138, 511-519. [Google Scholar] [CrossRef] [PubMed]
[67] Billoni, N., Buan, B., Gautier, B., et al. (2000) Expression of Peroxisome Proliferator Activated Receptors (PPARs) in Human Hair Follicles and PPAR α Involvement in Hair Growth. Acta Dermato-Venereologica, 80, 329-334. [Google Scholar] [CrossRef] [PubMed]
[68] Huang, C.F., Chang, Y.J., Hsueh, Y.Y., et al. (2016) Assembling Composite Dermal Papilla Spheres with Adipose-Derived Stem Cells to Enhance Hair Follicle Induction. Scientific Reports, 6, Article No. 26436. [Google Scholar] [CrossRef] [PubMed]
[69] Tan, N.S., Icre, G., Montagner, A., et al. (2007) The Nuclear Hormone Receptor Peroxisome Proliferator-Activated Receptor β/Delta Potentiates Cell Chemotactism, Polarization, and Migration. Molecular and Cellular Biology, 27, 7161-7175. [Google Scholar] [CrossRef
[70] Di-Poi, N., Ng, C.Y., Tan, N.S., et al. (2005) Epithelium-Mesenchyme Interactions Control the Activity of Peroxisome Proliferator-Activated Receptor β/Delta during Hair Follicle Development. Molecular and Cellular Biology, 25, 1696-1712. [Google Scholar] [CrossRef